1. AHRO : Austin Health Research Online

Peter W Angus

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Peter W Angus
Full Name
Angus, Peter W
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Results 61-80 of 187 (Search time: 0.012 seconds).

Publication YearTitleAuthor(s)
6121-Sep-2016Dietary advanced glycation end-products aggravate non-alcoholic fatty liver diseaseLeung, Christopher ; Herath, Chandana B; Jia, Zhiyuan; Andrikopoulos, Sofianos; Brown, Bronwyn E; Davies, Michael J; Rivera, Leni R; Furness, John B; Forbes, Josephine M; Angus, Peter W 
62Sep-2016Hepatitis C-induced hepatocyte apoptosis following liver transplantation is enhanced by immunosuppressive agents.Lim, Eu Jin ; Chin, Ruth; Nachbur, U; Silke, J; Jia, Zhiyuan; Angus, Peter W ; Torresi, Joseph 
63Sep-2016Acute oesophageal necrosis.Khan, Saad A; Thwaites, Phoebe A ; Braude, Michael; Lontos, Steve; Angus, Peter W 
6423-Aug-2016Medical resource utilization and costs among Australian patients with genotype 1 chronic hepatitis C: results of a retrospective observational studyMcElroy, Heather J; Roberts, Stuart K; Thompson, Alex J; Angus, Peter W ; McKenna, Sarah Jane; Warren, Emma; Musgrave, Sharon
65Jul-2016Outpatient terlipressin infusion for the treatment of refractory ascites.Gow, Paul J ; Ardalan, Zaid S M; Vasudevan, Abhinav ; Testro, Adam G ; Ye, Bei; Angus, Peter W 
66Jul-2016Efficacy of outpatient continuous terlipressin infusions for hepatorenal syndrome.Vasudevan, Abhinav ; Ardalan, Zaid S M; Gow, Paul J ; Angus, Peter W ; Testro, Adam G 
67Jul-2016The role of the gut microbiota in NAFLDLeung, Christopher ; Rivera, L; Furness, John B; Angus, Peter W 
681-Jun-2016Single-molecule sequencing reveals complex genomic variation of hepatitis B virus during 15 years of chronic infection following liver transplantationBetz-Stablein, BD; Töpfer, A; Littlejohn, M; Yuen, L; Colledge, D; Sozzi, V; Angus, Peter W ; Thompson, A; Revill, P; Beerenwinkel, N; Warner, N; Luciani, F
9Jun-2016Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.Manns, Michael; Samuel, Didier; Gane, Edward J; Mutimer, David; McCaughan, Geoff; Buti, Maria; Prieto, Martín; Calleja, José Luis; Peck-Radosavljevic, Markus; Müllhaupt, Beat; Agarwal, Kosh; Angus, Peter W ; Yoshida, Eric M; Colombo, Massimo; Rizzetto, Mario; Dvory-Sobol, Hadas; Denning, Jill; Arterburn, Sarah; Pang, Phillip S; Brainard, Diana; McHutchison, John G; Dufour, Jean-François; Van Vlierberghe, Hans; van Hoek, Bart; Forns, Xavier
10Jun-2016Risk stratification in acute upper GI bleeding: comparison of the AIMS65 score with the Glasgow-Blatchford and Rockall scoring systemsRobertson, Marcus ; Majumdar, Avik; Boyapati, Ray; Chung, William ; Worland, Tom; Terbah, Ryma ; Wei, James; Lontos, Steve; Angus, Peter W ; Vaughan, Rhys B 
113-May-2016Liver Failure Complicating a Febrile Illness in a Middle-Aged Man.Vasudevan, Abhinav ; Ardalan, Zaid S M; Angus, Peter W 
12May-2016Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: a randomized phase III study (ALLY-3+)Leroy, Vincent; Angus, Peter W ; Bronowicki, Jean-Pierre; Dore, Gregory J; Hezode, Christophe; Pianko, Stephen; Pol, Stanislas; Stuart, Katherine; Tse, Edmund; McPhee, Fiona; Bhore, Rafia; Jimenez-Exposito, Maria Jesus; Thompson, Alexander J
13May-2016Additive impact of pre-liver transplant metabolic factors on survival post-liver transplantAdams, Leon A; Arauz, Oscar; Angus, Peter W ; Sinclair, Marie ; MacDonald, Graeme A; Chelvaratnam, Utti; Wigg, Alan J; Yeap, Sze; Shackel, Nicholas; Lin, Linda; Raftopoulos, Spiro; McCaughan, Geoffrey W; Jeffrey, Gary P; Australian New Zealand Liver Transplant Study Group
14Apr-2016Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventionsSinclair, Marie ; Gow, Paul J ; Grossmann, Mathis ; Angus, Peter W 
15Mar-2016Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver disease.Sinclair, Marie ; Grossmann, Mathis ; Angus, Peter W ; Hoermann, Rudolf; Hey, Penelope ; Scodellaro, Thomas ; Gow, Paul J 
16Feb-2016The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New Zealand.Howell, Jessica; Balderson, Glenda; Hellard, Margaret; Gow, Paul; Strasser, Simone; Stuart, Katherine; Wigg, Alan; Jeffrey, Gary; Gane, Ed; Angus, Peter W 
176-Jan-2016Resolution of norfloxacin-induced acute liver failure after N-acetylcysteine therapy: further support for the use of NAC in drug-induced ALF?Elliott, Timothy Ross; Symes, Tiffany; Kannourakis, George; Angus, Peter W 
18Jan-2016Incretin-based therapies for the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysisCarbone, Laura J; Angus, Peter W ; Yeomans, Neville D 
192016Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinomaKazankov, Konstantin; Rode, Anthony; Simonsen, Kira; Villadsen, Gerda Elisabeth; Nicoll, Amanda J; Møller, Holger Jon; Lim, Lucy ; Angus, Peter W ; Kronborg, Ian; Arachchi, Niranjan; Gorelik, Alexandra; Liew, Danny; Vilstrup, Hendrik; Frystyk, Jan; Grønbæk, Henning
20Dec-2015Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantationSood, Siddharth ; Haifer, Craig; Yu, Lijia; Pavlovic, Julie ; Gow, Paul J ; Jones, Robert M ; Visvanathan, Kumar; Angus, Peter W ; Testro, Adam G